Related Experiment Videos
Adjunctive corticosteroid therapy in bacterial meningitis
1Department of Anaesthesia and Intensive Care, Copenhagen University Hospital, Herlev, Denmark.
Abstract:
Experimental studies of bacterial meningitis have shown that components of bacterial cell walls stimulate the local production of inflammatory cytokines in the cerebrospinal fluid, leading to inflammation and alterations in the cerebral microvasculature. Animal studies and clinical trials have demonstrated that adjunctive corticosteroid therapy reduces the production of cytokines in the CSF. This results in decreased severity of the inflammatory process and fewer neurologic sequelae. These data support the use of adjunctive dexamethasone in infants and children with S. pneumoniae and H. influenzae type B (HiB) meningitis. There is not sufficient evidence supporting the use of adjunctive corticosteroid therapy in children with meningitis caused by N. meningitidis. Also, the routine use of dexamethasone in adult meningitis cannot presently be recommended. When using dexamethasone timing is crucial. Administration before or with antibiotics is optimal for attenuating the subarachnoid space inflammatory response. Patients receiving the therapy need careful monitoring for the possibility of gastrointestinal bleeding. Future studies of the pathogenesis and pathophysiology of bacterial meningitis may lead to the development of other adjunctive treatment strategies, improving the outcome of this serious disease.
Insights
Adjunctive corticosteroid therapy, like dexamethasone, can reduce inflammation and neurological damage in children with bacterial meningitis. However, its use is not recommended for all types of meningitis or in adults.
Area of Science:
- Neuroscience
- Immunology
- Infectious Diseases
Background:
- Bacterial meningitis triggers inflammatory cytokine production in cerebrospinal fluid (CSF).
- This inflammation affects cerebral microvasculature and can lead to neurological damage.
- Corticosteroids, such as dexamethasone, have been investigated for their anti-inflammatory effects.
Purpose of the Study:
- To evaluate the efficacy of adjunctive corticosteroid therapy in managing bacterial meningitis.
- To determine the specific bacterial types and patient populations for whom this therapy is most beneficial.
- To identify optimal timing and potential risks associated with corticosteroid use.
Main Methods:
- Review of experimental studies on bacterial meningitis.
- Analysis of animal models demonstrating inflammatory responses.
- Examination of clinical trials assessing corticosteroid interventions.
Main Results:
- Adjunctive corticosteroids reduce cytokine production in CSF, decreasing inflammation and neurologic sequelae.
- Dexamethasone is supported for use in infants and children with S. pneumoniae and H. influenzae type B (HiB) meningitis.
- Evidence is insufficient for N. meningitidis meningitis in children and routine use in adults.
Conclusions:
- Dexamethasone is beneficial as an adjunctive therapy for specific types of pediatric bacterial meningitis.
- Optimal timing of dexamethasone administration is before or with antibiotics.
- Careful monitoring for gastrointestinal bleeding is necessary; further research into pathogenesis may yield new treatments.